Cargando…
Antibody titers against SARS-CoV-2 spike protein 6 months after a third BNT162b2 vaccine in chronic hemodialysis patients
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9155231/ https://www.ncbi.nlm.nih.gov/pubmed/35664285 http://dx.doi.org/10.1093/ckj/sfac087 |
_version_ | 1784718199460200448 |
---|---|
author | El Haggan, Wael Berdin, Bruno El Salhy, Magdy |
author_facet | El Haggan, Wael Berdin, Bruno El Salhy, Magdy |
author_sort | El Haggan, Wael |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-9155231 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-91552312022-06-04 Antibody titers against SARS-CoV-2 spike protein 6 months after a third BNT162b2 vaccine in chronic hemodialysis patients El Haggan, Wael Berdin, Bruno El Salhy, Magdy Clin Kidney J Letter to the Editor Oxford University Press 2022-03-31 /pmc/articles/PMC9155231/ /pubmed/35664285 http://dx.doi.org/10.1093/ckj/sfac087 Text en © The Author(s) 2022. Published by Oxford University Press on behalf of the ERA. https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (https://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com |
spellingShingle | Letter to the Editor El Haggan, Wael Berdin, Bruno El Salhy, Magdy Antibody titers against SARS-CoV-2 spike protein 6 months after a third BNT162b2 vaccine in chronic hemodialysis patients |
title | Antibody titers against SARS-CoV-2 spike protein 6 months after a third BNT162b2 vaccine in chronic hemodialysis patients |
title_full | Antibody titers against SARS-CoV-2 spike protein 6 months after a third BNT162b2 vaccine in chronic hemodialysis patients |
title_fullStr | Antibody titers against SARS-CoV-2 spike protein 6 months after a third BNT162b2 vaccine in chronic hemodialysis patients |
title_full_unstemmed | Antibody titers against SARS-CoV-2 spike protein 6 months after a third BNT162b2 vaccine in chronic hemodialysis patients |
title_short | Antibody titers against SARS-CoV-2 spike protein 6 months after a third BNT162b2 vaccine in chronic hemodialysis patients |
title_sort | antibody titers against sars-cov-2 spike protein 6 months after a third bnt162b2 vaccine in chronic hemodialysis patients |
topic | Letter to the Editor |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9155231/ https://www.ncbi.nlm.nih.gov/pubmed/35664285 http://dx.doi.org/10.1093/ckj/sfac087 |
work_keys_str_mv | AT elhagganwael antibodytitersagainstsarscov2spikeprotein6monthsafterathirdbnt162b2vaccineinchronichemodialysispatients AT berdinbruno antibodytitersagainstsarscov2spikeprotein6monthsafterathirdbnt162b2vaccineinchronichemodialysispatients AT elsalhymagdy antibodytitersagainstsarscov2spikeprotein6monthsafterathirdbnt162b2vaccineinchronichemodialysispatients |